Paroxetine-mediated GRK2 inhibition (investigational approach)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Paroxetine-mediated GRK2 inhibition (investigational approach), covering 2022-06-01 to 2022-06-01. Get the full timeline:
Most recent: Clinical Trial Update: Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction [Phase 2]